Status:
COMPLETED
Effects of Continuous Infusion of Intravenous Nefopam on Postoperative Pain and Opioid Consumption After VATS
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Pharmbio Korea
Conditions:
Postoperative Pain
Eligibility:
All Genders
19-70 years
Phase:
NA
Brief Summary
This prospective, randomized, double-blinded study is designed to evaluate the postoperative analgesic effect of the continuous infusion of intravenous nefopam in patients undergoing video-assisted th...
Detailed Description
Adult patients undergoing elective unilateral VATS segmentectomy or lobectomy are randomly allocated to receive continuous nefopam infusion (n=45) or not (n=45), in addition to a standard postoperativ...
Eligibility Criteria
Inclusion
- Patients scheduled to undergo elective unilateral VATS segmentectomy or lobectomy under general anesthesia
- American Society of Anesthesiologists (ASA) physical classification I-II
- Consent to IV-patient controlled analgesia use
- Willingness and ability to sign an informed consent document
Exclusion
- Do not understand our study
- Allergies to anesthetic or analgesic medications
- Continuous local anesthetics infiltration for postoperative pain control
- Patients who receive mechanical ventilation more than 2 hours after surgery
- Pregnancy/Breast feeder
- Medical or psychological disease that can affect the treatment response
Key Trial Info
Start Date :
July 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 10 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04450355
Start Date
July 30 2020
End Date
November 10 2021
Last Update
May 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, KS013